Skip to content
Top Menu
  • Log In
  • Register
  • Facebook
  • Twitter
  • LinkedIn
MyChesCo

MyChesCo

Chester County News and Community Website

  • Communities
    • Avondale
    • Berwyn
    • Coatesville
    • Cochranville
    • Devon
    • Downingtown
    • Exton
    • Honey Brook
    • Kennett Square
    • Malvern
    • Oxford
    • Paoli
    • Parkesburg
    • Phoenixville
    • Spring City
    • Toughkenamon
    • West Chester
    • West Grove
  • Education
    • Chester County Intermediate Unit
    • School Districts
      • Avon Grove School District
      • Coatesville Area School District
      • Downingtown Area School District
      • Great Valley School District
      • Kennett Consolidated School District
      • Octorara Area School District
      • Owen J. Roberts School District
      • Oxford Area School District
      • Phoenixville Area School District
      • Spring-Ford Area School District
      • Tredyffrin-Easttown School District
      • Twin Valley School District
      • Unionville-Chadds Ford School District
      • West Chester Area School District
    • Charter Schools
    • Independent Schools
    • Colleges and Universities
    • Chester County Library System
  • News
    • Traffic
    • Weather
    • Business
    • Health / Medical
    • National
    • Pennsylvania
    • Sports
  • Entertainment
  • Lifestyle
  • Tools
    • Members
    • Groups
    • Submit an Article
    • Contact Us
    • Signup for Newsletter
    • Contests and Giveaways
    • Gas Prices
    • Register
    • Log In
  • About
    • MyChesCo
    • Writing for Us
    • Advertising with Us
    • Contacting Us
    • Citizen Journalism
    • Submitting Articles
    • Starting a Group
    • How to Support Us
    • Terms of Service
    • Privacy Policy
    • DMCA Policy
    • AI Disclosure
  • Shop

Government Administration Activities

Johnson & Johnson
Regional

FDA Approves Johnson & Johnson’s IMAAVY for Generalized Myasthenia Gravis

May 2, 2025April 30, 2025 - by Timothy Alexander

SPRING HOUSE, PA — On Wednesday, the U.S. Food and Drug Administration (FDA) granted approval for IMAAVY™ (nipocalimab-aahu), Johnson & Johnson’s cutting-edge FcRn-blocking antibody treatment for generalized myasthenia gravis (gMG). …

FDA Approves Johnson & Johnson’s IMAAVY for Generalized Myasthenia Gravis Read More

Orchestra BioMed Holdings
Regional

Orchestra BioMed Secures FDA Clearance for Virtue Trial to Advance Coronary ISR Treatment

May 1, 2025April 30, 2025 - by Timothy Alexander

NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) has received FDA approval to move forward with its Virtue Trial, a pivotal clinical study designed to evaluate its next-generation …

Orchestra BioMed Secures FDA Clearance for Virtue Trial to Advance Coronary ISR Treatment Read More
PA CareerLink Lancaster County
Pennsylvania

Pennsylvania Launches Initiative to Provide On-the-Spot Birth Certificates

April 30, 2025April 29, 2025 - by Maryann Pugh

LANCASTER, PA — The Pennsylvania Departments of Labor & Industry (L&I) and Health (DOH) have introduced a new initiative allowing residents to receive on-the-spot birth certificates at PA CareerLink® locations. …

Pennsylvania Launches Initiative to Provide On-the-Spot Birth Certificates Read More

U.S. Department of Agriculture
National / Social Services

USDA Tightens SNAP Eligibility Verification to Align with Executive Order 14218

April 27, 2025April 26, 2025 - by Maryann Pugh

WASHINGTON, D.C. — The U.S. Department of Agriculture (USDA) has introduced new measures to strengthen the verification of identity and immigration status for Supplemental Nutrition Assistance Program (SNAP) applicants. The …

USDA Tightens SNAP Eligibility Verification to Align with Executive Order 14218 Read More
Orchestra BioMed Holdings
Regional

Orchestra BioMed Secures FDA Breakthrough Device Designation for AVIM Therapy

April 23, 2025April 22, 2025 - by Timothy Alexander

NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) announced that its atrioventricular interval modulation (AVIM) therapy has received Breakthrough Device Designation (BDD) from the U.S. Food and Drug …

Orchestra BioMed Secures FDA Breakthrough Device Designation for AVIM Therapy Read More

Aclaris Therapeutics
Products and Services

Aclaris Therapeutics Secures FDA Clearance for ATI-052 Clinical Trial

April 23, 2025April 22, 2025 - by Timothy Alexander

WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) has announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application for ATI-052, a bispecific …

Aclaris Therapeutics Secures FDA Clearance for ATI-052 Clinical Trial Read More
GSK plc
Regional

CDC Panel Recommends GSK’s New PENMENVY Vaccine for Adolescents

April 23, 2025April 21, 2025 - by Timothy Alexander

PHILADELPHIA, PA — The U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) has recommended the inclusion of GSK’s PENMENVY vaccine in the adolescent meningococcal …

CDC Panel Recommends GSK’s New PENMENVY Vaccine for Adolescents Read More

Food and Drug Administration
National

FDA Implements New Policy to Restrict Industry Ties on Advisory Committees

April 20, 2025April 19, 2025 - by Maryann Pugh

WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has announced a new policy directive to limit employees of FDA-regulated companies, such as pharmaceutical firms, from serving as official …

FDA Implements New Policy to Restrict Industry Ties on Advisory Committees Read More
U.S. Department of Agriculture
National

Why the USDA Just Cut Federal Funds to Maine Schools Over Title IX Conflicts

April 7, 2025April 7, 2025 - by Maryann Pugh

WASHINGTON, D.C. — U.S. Secretary of Agriculture Brooke Rollins has announced a suspension of federal funding for specific Maine educational programs, citing the state’s noncompliance with Title IX protections. The …

Why the USDA Just Cut Federal Funds to Maine Schools Over Title IX Conflicts Read More
Medical
Regional

FDA Approves GSK’s Blujepa as First New Oral Antibiotic for UTIs in 30 Years

March 31, 2025March 30, 2025 - by Timothy Alexander

PHILADELPHIA, PA — The U.S. Food and Drug Administration (FDA) has approved GSK’s Blujepa (gepotidacin), a groundbreaking oral antibiotic for treating uncomplicated urinary tract infections (uUTIs) in adult women and adolescents …

FDA Approves GSK’s Blujepa as First New Oral Antibiotic for UTIs in 30 Years Read More

Posts pagination

Previous 1 … 7 8 9 … 15 Next

Trending News

  • Parking Lot Confrontation Ends in Assault, DUI Allegations at Pine Road Business

  • Raw Oysters Under Fire as Salmonella Sickens Dozens Across the U.S.

  • Pennsylvania Workers Leave More Vacation Time Unused Than Any State in 2025

  • Santa’s Surprise Turns Breakfast Into a Moment No One Expected

  • Health Inspectors Flag Multiple Food Safety Issues at Popular West Chester Restaurant

Subscribe for Updates

Follow Us

  • Facebook
  • X
  • LinkedIn
  • Google
  • RSS Feed

Tools

  • Members
  • Newsletter
  • Events
  • Groups
  • Guest Articles
  • Coupon Center
  • Gas Prices
  • Log In
  • Register

About Us

  • About MyChesCo
  • Advertise
  • Contact Us
  • Support Us
  • Write for Us
  • Terms of Service
  • Privacy Policy
  • DMCA Policy
  • Affiliate Disclaimer

Recommended Reading

Soso Shioshvili

Parking Lot Confrontation Ends in Assault, DUI Allegations at Pine Road Business

December 27, 2025December 26, 2025

Breakfast with Santa

Santa’s Surprise Turns Breakfast Into a Moment No One Expected

December 27, 2025December 27, 2025

Court News

Trust Betrayed: Pennsylvania County Man Gets 8 to 20 Years for Child Sex Assault

December 26, 2025December 24, 2025

Copyright © 2025 MyChesCo.